- Home
- ASMB vs NCT Comparison
ASMB vs NCT Comparison
Compare ASMB & NCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- NCT
- Stock Information
- Founded
- ASMB 2005
- NCT 2011
- Country
- ASMB United States
- NCT Hong Kong
- Employees
- ASMB N/A
- NCT N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- NCT
- Sector
- ASMB Health Care
- NCT
- Exchange
- ASMB Nasdaq
- NCT NYSE
- Market Cap
- ASMB 141.8M
- NCT 114.7M
- IPO Year
- ASMB 2010
- NCT 2025
- Fundamental
- Price
- ASMB $18.51
- NCT $4.00
- Analyst Decision
- ASMB Strong Buy
- NCT
- Analyst Count
- ASMB 3
- NCT 0
- Target Price
- ASMB $33.00
- NCT N/A
- AVG Volume (30 Days)
- ASMB 43.3K
- NCT 35.0K
- Earning Date
- ASMB 08-07-2025
- NCT 01-01-0001
- Dividend Yield
- ASMB N/A
- NCT N/A
- EPS Growth
- ASMB N/A
- NCT N/A
- EPS
- ASMB N/A
- NCT 0.13
- Revenue
- ASMB $32,154,000.00
- NCT $25,526,936.00
- Revenue This Year
- ASMB $0.04
- NCT N/A
- Revenue Next Year
- ASMB N/A
- NCT N/A
- P/E Ratio
- ASMB N/A
- NCT $32.84
- Revenue Growth
- ASMB 148.33
- NCT N/A
- 52 Week Low
- ASMB $7.75
- NCT $3.05
- 52 Week High
- ASMB $19.93
- NCT $8.76
- Technical
- Relative Strength Index (RSI)
- ASMB 63.34
- NCT N/A
- Support Level
- ASMB $18.13
- NCT N/A
- Resistance Level
- ASMB $19.11
- NCT N/A
- Average True Range (ATR)
- ASMB 0.81
- NCT 0.00
- MACD
- ASMB -0.06
- NCT 0.00
- Stochastic Oscillator
- ASMB 77.83
- NCT 0.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About NCT INTERCONT (CAYMAN) LIMITED
Intercont (Cayman) Ltd operates through its subsidiaries. It is principally engaged in the time charter service and vessel management services business.